CanSino Biologics Inc Class H 06185
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 21.15
- Day Range
- HKD 20.45–21.80
- 52-Week Range
- HKD 14.80–36.50
- Bid/Ask
- HKD 21.75 / HKD 21.80
- Market Cap
- HKD 5.38 Bil
- Volume/Avg
- 736,600 / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 11.21
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,494
- Website
- https://www.cansinotech.com
Comparables
Valuation
|
Metric
|
06185
|
300142
|
06660
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 44.91 | 36.08 |
Price/Book Value | 0.96 | 2.53 | 2.68 |
Price/Sales | 11.21 | 6.07 | 8.18 |
Price/Cash Flow | — | 27.55 | — |
Price/Earnings
06185
300142
06660
Financial Strength
|
Metric
|
06185
|
300142
|
06660
|
|---|---|---|---|
Quick Ratio | 2.20 | 2.46 | 0.74 |
Current Ratio | 2.39 | 2.85 | 0.95 |
Interest Coverage | −28.32 | 47.19 | −51.05 |
Quick Ratio
06185
300142
06660
Profitability
|
Metric
|
06185
|
300142
|
06660
|
|---|---|---|---|
Return on Assets (Normalized) | −20.95% | 3.37% | −3.57% |
Return on Equity (Normalized) | −35.51% | 5.57% | −6.57% |
Return on Invested Capital (Normalized) | −25.25% | 3.91% | −4.09% |
Return on Assets
06185
300142
06660
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Tprdcjnvw | Dkbz | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Pdwpcywjz | Jfhnjt | $70.9 Bil | |
HLN
| Haleon PLC ADR | Jdvztkbyj | Yfbk | $37.8 Bil | |
VTRS
| Viatris Inc | Rswxdcj | Wtmgq | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tsnmzxwk | Rchv | $12.7 Bil | |
CTLT
| Catalent Inc | Jbvgsxsc | Ksxczq | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Rvmfxwhh | Zygx | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Qmkbbzdh | Stmh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Nshqfzgy | Ngrsdd | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Hyzzxzvv | Ldlf | $3.1 Bil |